• 검색 결과가 없습니다.

Defibrotide Treatment for Hepatic Veno-occlusive Disease after Umbilical Cord Blood Transplantation

N/A
N/A
Protected

Academic year: 2021

Share "Defibrotide Treatment for Hepatic Veno-occlusive Disease after Umbilical Cord Blood Transplantation"

Copied!
5
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Fig.  1.  Bilirubin  changes  as  a  manifestation  of  hepatic  veno-occulsive  disease  after  umbilical  cord  transplantation

참조

관련 문서

Severe disease activity and cy- tomegalovirus colitis are predictive of a nonresponse to infliximab in patients with ulcerative colitis. Guidelines for the management of

• Theory can extent to molten polymers and concentrated solutions.. The single-molecule bead spring models.. a)

This research is a research to examine change in physical strengh, thickness of subcutaneous fat, and blood lipid after twelve week execution of

Serum uric acid levels and risk for vascular disease in patients with metabolic syndrome... Prevalence if the metabolic syndrome in a Turkish

Meterials and Methods: Our study involved three stem cell sources-subacromial bursal tissue, bone marrow, and umbilical cord-derived stem cells. Under consent we

The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new‑onset type 2

Background: Incidence of complications related extracorporeal membrane oxygenation (ECMO) support as a bridge to lung transplantation (BTT) and its association with the

Effect of faecal microbiota transplan- tation for treatment of Clostridium difficile infection in patients with inflammatory bowel disease: a systematic review and meta-analysis